Utilities associated with diabetic retinopathy: results from a Canadian sample.
about
Patient perceptions of quality of life with diabetes-related complications and treatmentsThe effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity.The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration.Impact of Diabetic Retinopathy on Health-related Quality of Life in Iranian Diabetics.Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review.Utility values associated with diabetic retinopathy in Chennai, India.Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants.Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration.Disparities between Ophthalmologists and Patients in Estimating Quality of Life Associated with Diabetic RetinopathyThe longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy.Health utility values associated with diabetic retinopathy.Variation in treatment preferences and care goals among older patients with diabetes and their physiciansImpact of visual impairment on service and device use by individuals with diabetic retinopathy.A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation.Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada.Utility values and myopia in medical students in Singapore.Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited.
P2860
Q24644699-7A90DA74-5690-461C-A07B-979299D590CFQ30654773-54F3A1EB-52A4-4FC0-94B1-902758579F52Q33329793-144B3000-0B66-4915-9CC4-556FE066B2BCQ33593570-8D027727-039E-4EA4-BDE2-66775B028E06Q35059037-C8DB1521-A81E-43E9-A7AA-D6A0E561A781Q35131740-D494E235-4E83-4244-ADA6-BE77AF2FA156Q35591903-E5EA8B9B-4891-43A5-A02D-7856CCFAF8A8Q35592283-4F562E71-3D0D-4A71-9FA0-F3751A6CC0B4Q35859211-81BC5339-E47B-45C2-BE37-E366F9FE3162Q37035811-1832CDB6-AC31-4D64-998D-8418F3659C15Q37111972-4D4E36CB-A13A-424B-9172-EB959E3E643FQ37137827-924D80D7-EDB3-4742-9A41-C57D580C1155Q37353974-79392674-A558-47C1-A844-E13ABBE35619Q37862622-BD6F46B3-0760-4CCD-BA79-9F7797BBF393Q39795027-031B0427-900E-49A6-9214-CE849A668BFEQ40359217-48597AFB-1D24-428A-A045-23CFEC9349BFQ48450020-22C76709-C9EB-4C71-BB11-3C8EAFE7AB24Q53438701-FAF9E8AF-E81D-4D9D-BD06-9879DA0A9E48
P2860
Utilities associated with diabetic retinopathy: results from a Canadian sample.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Utilities associated with diabetic retinopathy: results from a Canadian sample.
@ast
Utilities associated with diabetic retinopathy: results from a Canadian sample.
@en
type
label
Utilities associated with diabetic retinopathy: results from a Canadian sample.
@ast
Utilities associated with diabetic retinopathy: results from a Canadian sample.
@en
prefLabel
Utilities associated with diabetic retinopathy: results from a Canadian sample.
@ast
Utilities associated with diabetic retinopathy: results from a Canadian sample.
@en
P2093
P2860
P356
P1476
Utilities associated with diabetic retinopathy: results from a Canadian sample.
@en
P2093
A Oliver-Fernandez
H Hollands
P2860
P304
P356
10.1136/BJO.87.3.259
P407
P577
2003-03-01T00:00:00Z